Symptomatic Liver Cyst Successfully Treated with Transgastric Drainage and Sclerotherapy Using Minocycline Hydrochloride

Table 1

Laboratory data on admission.

Hematology
WBC	5,700 (μL)
RBC	403 × 10^4 (μL)
Hb	12.9 g/dL
Ht	39.3%
Plt	18.6 × 10^4 (μL)
Biochemistry
TP	7.5 g/dL
Alb	4.4 g/dL
T-bil	0.62 mg/dL
AST	27 IU/L
ALT	20 IU/L
LDH	263 IU/L
ALP	181 IU/L
GGT	14 IU/L
BUN	13.2 mg/dL
Cre	0.51 mg/dL
Na	142 mEq/L
K	4.3 mEq/L
FPG	70 mg/dL
Serology
CRP	0.18 mg/dL
Coagulation
PT%	116%
PT-INR	0.93
APTT	28.2 sec
Viral markers
HBsAg	(−)
HBcAb	(−)
HCVAb	(−)
Tumor markers
CEA	6.2 ng/mL
CA19-9	38.2 U/mL

RBC: red blood cell, WBC: white blood cell, Hb: hemoglobin, Ht: hematocrit, Plt: platelet, TP: total protein, Alb: albumin, T-bil: total bilirubin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, ALP: alkaline phosphatase, GGT: γ-glutamyltransferase, BUN: blood urea nitrogen, Cre: creatinine, Na: natrium, K: kalium, FPG: fasting plasma glucose, CRP: C-reactive protein, PT%: prothrombin time, APTT: activated partial thromboplastin time, HBsAg: HBs antigen, HBcAb: HBs antibody, HCVAb: HCV antibody, CEA: carcinoembryonic antigen, and CA19-9: carbohydrate antigen 19-9.